4//SEC Filing
DWEK RAYMOND 4
Accession 0001562180-25-003225
CIK 0001082554other
Filed
Apr 21, 8:00 PM ET
Accepted
Apr 22, 4:30 PM ET
Size
8.6 KB
Accession
0001562180-25-003225
Insider Transaction Report
Form 4
DWEK RAYMOND
Director
Transactions
- Sale
Common Stock
2025-04-21$285.57/sh−3,000$856,710→ 1,750 total - Exercise/Conversion
Stock Option
2025-04-21−3,000→ 0 totalExercise: $175.43From: 2016-06-26Exp: 2025-06-26→ Common Stock (3,000 underlying) - Exercise/Conversion
Common Stock
2025-04-21$175.43/sh+3,000$526,290→ 4,750 total
Footnotes (1)
- [F1]This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 2, 2024.
Documents
Issuer
UNITED THERAPEUTICS Corp
CIK 0001082554
Entity typeother
Related Parties
1- filerCIK 0001231617
Filing Metadata
- Form type
- 4
- Filed
- Apr 21, 8:00 PM ET
- Accepted
- Apr 22, 4:30 PM ET
- Size
- 8.6 KB